Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Price, Quote & AI Analysis
Live ANL stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Adlai Nortye Ltd. American Depositary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Adlai Nortye Ltd. American Depositary Shares (ANL), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Adlai Nortye Ltd. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Adlai Nortye Ltd. American Depositary Shares Overview
Company information
Company Overview
Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Adlai Nortye Ltd. American Depositary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...